In the present study, our data showed that SLC26A9 promoted the occurrence and development of CRC, and its expression was significantly increased in the protein analysis of clinical CRC samples, in CRC cells, and in The Cancer Genome Atlas (TCGA) database (Supplementary Fig. 4). The gene discussed is SLC26A9; the disease is colorectal carcinoma.